Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.048 | 0.9 |